Here, we demonstrate that TAZ functions as an oncogene in HPV18+ (and HPV18-like), but not HPV16+ cervical cancer, highlighting a key difference between HPV16- and HPV18-driven cervical disease. This evidence concerns the gene WWTR1 and cervical cancer.